Search Within

Jessica Flynn

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Journal Article (28)
  2. Meeting Abstract (26)
  3. Correspondence (1)
  4. Miscellaneous (1)
Groups
  1. CTCR Scholars (56)
  2. Department of Medicine (56)
  3. MSK Grad Students (56)
  4. Master of Science in Clinical and Translational Cancer Research (56)
  5. Biostatistics Service (55)
  6. Epidemiology and Biostatistics (55)

More Groups

People
  1. Miguel-Angel Perales (52)
  2. Sean Devlin (51)
  3. Parastoo Dahi (45)
  4. Gunjan Shah (43)
  5. Michael Scordo (41)
  6. Maria Palomba (36)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (15)
  4. 2022 (13)
  5. 2021 (5)
  6. 2020 (8)

More Years

Publications
  1. Blood (12)
  2. Transplantation and Cellular Therapy (10)
  3. Bone Marrow Transplantation (9)
  4. Blood Advances (5)
  5. Annals of Surgical Oncology (2)
  6. Blood Cancer Journal (2)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. Elsevier Inc. (15)
  3. Nature Publishing Group (12)
  4. American Society of Clinical Oncology (2)
  5. Ferrata Storti Foundation (2)
  6. Springer (2)

More Publishers

Results (56)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessment of frailty can guide decision making for utilization of sentinel lymph node biopsy in patients with thick melanoma
    Journal Article

    Sharma, A. S.; Flynn, J. R.; Panageas, K. S.; Shahrokni, A.; Tin, A. L.; Bello, D. M.; Ariyan, C. E.; Brady, M. S.; Coit, D. G.; Bartlett, E. K.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Letermovir for prevention of cytomegalovirus reactivation in haploidentical and mismatched adult donor allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis
    Journal Article

    Lin, A.; Flynn, J.; DeRespiris, L.; Figgins, B.; Griffin, M.; Lau, C.; Proli, A.; Devlin, S. M.; Cho, C.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • The International Prognostic Index is associated with outcomes in diffuse large B cell lymphoma after chimeric antigen receptor T cell therapy
    Journal Article

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Shouval, R.; Afuye, A. O.; Silverberg, M. L.; Batlevi, C. W.; Dahi, P.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Pharmacokinetics of melphalan in lymphoma patients undergoing beam and autologous hematopoietic stem cell transplant
    Meeting Abstract

    Dahi, P.; Lin, A.; Flynn, J.; Uruburo, C.; Mcgeary, I.; Schofield, R.; Bhatt, V.; Derespiris, L.; Figgins, B.; Griffin, M.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells
    Meeting Abstract

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
    Journal Article

    Wudhikarn, K.; Palomba, M. L.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Devlin, S. M.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Shah, G. L.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality
    Journal Article

    Wudhikarn, K.; Pennisi, M.; Garcia-Recio, M.; Flynn, J. R.; Afuye, A.; Silverberg, M. L.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; Shah, G. L.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save